Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BCTX

BriaCell Therapeutics Corp

Dec 11 • 04:00PM ET

1.10

Dollar change +0.02
Percentage change 1.85	%

Healthcare • Biotechnology • Canada • NASD

Peers: GILD PBYI JNJ EXEL BMY MRK BLUE AZN FOLD AMGN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.16	Insider Own	10.17%	Shs Outstand	36.18M	Perf Week	5.77%
Market Cap	39.80M	Forward P/E	-	EPS next Y	-0.84	Insider Trans	0.00%	Shs Float	32.50M	Perf Month	62.48%
Income	-4.79M	PEG	-	EPS next Q	-0.08	Inst Own	7.33%	Short Float	2.24%	Perf Quarter	74.60%
Sales	0.00M	P/S	-	EPS this Y	-46.39%	Inst Trans	30.93%	Short Ratio	0.14	Perf Half Y	-16.03%
Book/sh	-0.13	P/B	-	EPS next Y	30.86%	ROA	-29.01%	Short Interest	0.73M	Perf Year	-75.93%
Cash/sh	0.02	P/C	46.28	EPS next 5Y	-	ROE	-202.12%	52W Range	0.46 - 5.97	Perf YTD	-81.20%
Dividend Est.	-	P/FCF	-	EPS past 5Y	47.85%	ROI	-	52W High	-81.57%	Beta	1.46
Dividend TTM	-	Quick Ratio	0.49	Sales past 5Y	0.00%	Gross Margin	-	52W Low	137.02%	ATR (14)	0.13
Dividend Ex-Date	-	Current Ratio	0.49	EPS Y/Y TTM	77.67%	Oper. Margin	-	RSI (14)	60.72	Volatility	18.81% 14.81%
Employees	-	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	15.00
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	55.52%	Payout	-	Rel Volume	1.65	Prev Close	1.08
Sales Surprise	-	EPS Surprise	86.54%	Sales Q/Q	-	Earnings	Oct 24	Avg Volume	5.32M	Price	1.10
SMA20	29.58%	SMA50	28.83%	SMA200	-19.93%	Trades		Volume	8,809,341	Change	1.85%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-14-22	Initiated	H.C. Wainwright	Buy	$25

Dec-11-24 11:54PM	BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering (GlobeNewswire)
04:05PM	BriaCell Therapeutics Announces Proposed Public Offering (GlobeNewswire)
07:50AM	BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS (GlobeNewswire)
Dec-02-24 10:18AM	Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend (PR Newswire) +12.99%
07:50AM	BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer (GlobeNewswire)
07:50AM	Loading…
Nov-26-24 07:50AM	BriaCell 2024 SABCS Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer (GlobeNewswire) +9.71%
Nov-25-24 07:50AM	BriaCell Provides Update to its Board of Directors (GlobeNewswire) -6.67%
Nov-21-24 07:50AM	BriaCell Announces First Patient Dosed with Bria-OTS in Metastatic Breast Cancer Study (GlobeNewswire) +31.00%
Nov-08-24 07:50AM	BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference (GlobeNewswire)
Nov-04-24 07:50AM	BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium , December 10 13 (GlobeNewswire)
Oct-22-24 07:50AM	BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data (GlobeNewswire) +9.55%
Oct-15-24 07:50AM	BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study (GlobeNewswire)
Oct-02-24 04:05PM	BriaCell Therapeutics Announces Closing of $5 Million Offering (GlobeNewswire) +24.69%
Oct-01-24 02:05PM	BriaCell Therapeutics Announces $5 Million Offering (GlobeNewswire) -34.68%
07:50AM	BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with "Eye-Bulging" Tumor (GlobeNewswire)
07:50AM	Loading…
Sep-18-24 07:50AM	BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients (GlobeNewswire) +11.34%
Sep-12-24 04:05PM	BriaCell Therapeutics Announces Closing of $8.5 Million Offering (GlobeNewswire) -11.03%
Sep-11-24 12:09PM	BriaCell Therapeutics Announces $8.5 Million Offering (GlobeNewswire)
07:50AM	BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer (GlobeNewswire)
Sep-10-24 07:50AM	BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+ for Prostate Cancer (GlobeNewswire) -8.90%
Sep-09-24 07:50AM	BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire) -6.72%
Jul-18-24 07:56AM	BriaCell Quadruples Progression Free Survival (PFS) in Patient with Eye-Bulging Metastatic Breast Cancer (GlobeNewswire) -17.49%
Jun-14-24 09:52PM	BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024 (InvestorPlace)
Jun-03-24 08:00AM	BriaCell Presents Clinical Efficacy Data at ASCO 2024 (GlobeNewswire) -9.47%
May-30-24 08:00AM	BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer (GlobeNewswire)
May-28-24 08:00AM	BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study (GlobeNewswire)
07:27AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-24-24 08:00AM	BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024 (GlobeNewswire)
May-21-24 07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-17-24 04:33PM	BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering (GlobeNewswire) +7.19%
08:00AM	Loading…
May-15-24 08:00AM	BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering (GlobeNewswire) -22.75%
Apr-24-24 08:00AM	BriaCell Announces Oral and Poster Presentations at ASCO 2024 (GlobeNewswire) -5.60%
Apr-10-24 08:00AM	BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+ and Bria-PROS+ Clinical Candidates for Breast and Prostate Cancer (GlobeNewswire)
Apr-09-24 08:00AM	BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR (GlobeNewswire)
Mar-19-24 06:52AM	BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024 (InvestorPlace) -6.55%
Mar-07-24 08:00AM	BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies (GlobeNewswire) -7.05%
Mar-06-24 08:00AM	BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference (GlobeNewswire) -8.24%
Feb-27-24 08:00AM	BriaCell Provides Update on Alleged Illegal Trading of Public Securities (GlobeNewswire)
Feb-07-24 08:00AM	BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case (GlobeNewswire)
Feb-06-24 08:30AM	Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing (GlobeNewswire) +5.34%
Jan-30-24 10:48PM	BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting (GlobeNewswire)
Jan-04-24 08:45AM	BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with Eye-Bulging Metastatic Breast Cancer (GlobeNewswire) +6.60%
Dec-28-23 08:55AM	BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients (GlobeNewswire)
Dec-20-23 08:40AM	BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset (GlobeNewswire)
Dec-06-23 09:31AM	BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS (GlobeNewswire)
09:00AM	BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit (GlobeNewswire)
Nov-30-23 07:00AM	BriaCell Records New Responder with Remarkable Improvement of Eye-Bulging Metastatic Tumor (GlobeNewswire)
Nov-03-23 08:31AM	BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS IND (GlobeNewswire) +9.41%
Nov-01-23 10:49AM	BCTX: Year in Review (Zacks) -7.53%
Oct-25-23 09:15AM	BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology Candidate (GlobeNewswire)
Oct-20-23 09:15AM	October is Breast Cancer Awareness Month BriaCell is Leading the Fight with its Innovative Technology (GlobeNewswire) -5.51%
Oct-18-23 09:00AM	BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences (GlobeNewswire) -5.26%
Oct-11-23 09:10AM	BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo Clinic (GlobeNewswire)
Oct-04-23 09:00AM	BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT in Advanced Breast Cancer (GlobeNewswire)
Oct-03-23 09:00AM	BriaCell Initiates Pivotal Phase 3 Study of Bria-IMT in Advanced Metastatic Breast Cancer (GlobeNewswire)
Sep-08-23 07:00AM	BriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer (GlobeNewswire)
Aug-31-23 11:54AM	BriaCell Therapeutics Corp. Announces Closing of Plan of Arrangement Spinning Out BriaPro Therapeutics Corp. to Existing Shareholders (GlobeNewswire)
08:21AM	BriaCell Accepts Letter of Intent from Weill Cornell Medicine Outlining Plans to Initiate a Clinical Trial of Bria-IMT in High-Risk Early-Stage Triple Negative Breast Cancer (GlobeNewswire)
Aug-25-23 02:33PM	BriaCell Receives Court Approval for the Share Arrangement Spinning Out BriaPro Therapeutics (SpinCo) to Existing Shareholders (GlobeNewswire)
Aug-18-23 12:21PM	BriaCell Therapeutics Corp. Announces Voting Results From Special Meeting (GlobeNewswire)
Aug-16-23 08:36AM	BriaCell Awarded National Cancer Institute Grant to Advance its Bria-OTS Immunotherapy for Cancer (GlobeNewswire)
Jul-10-23 07:00AM	BCTX: Pivotal Study Protocol Cleared (Zacks)
Jun-27-23 08:05AM	FDA Approves BriaCells Pivotal Registrational Study Design in Advanced Metastatic Breast Cancer (GlobeNewswire) -7.99%
May-25-23 09:00AM	BriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp. (GlobeNewswire)
May-19-23 11:38AM	BriaCell Closes $4 Million Strategic Investment by Prevail Partners, LLC at US$8.63 per Share (GlobeNewswire) +5.59%
May-15-23 08:00AM	BriaCell Announces $4 Million Strategic Investment and Clinical Alliance with Prevail Partners, LLC and Prevail InfoWorks, Inc. (GlobeNewswire)
Apr-27-23 05:33AM	BCTX: Posters Galore at AACR (Zacks Small Cap Research)
Apr-17-23 07:45AM	BriaCell Presents Positive Data Demonstrating Survival and Clinical Benefits in Advanced Metastatic Breast Cancer at the 2023 AACR (GlobeNewswire) +5.28%
Apr-10-23 07:29AM	BriaCell Therapeutics (TSE:BCT) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Mar-30-23 08:45AM	BriaCell Announces Intention to Spin-Out Certain Pre-Clinical Assets into a Newly Created SpinCo Entity whereby Shareholders to Receive One New Share of SpinCo in Addition to Each Current Share of BriaCell Already Held (GlobeNewswire)
Mar-15-23 09:15AM	BriaCell to Present Clinical and Survival Data in Advanced Metastatic Breast Cancer at the 2023 AACR Annual Meeting (GlobeNewswire)
Mar-14-23 06:27AM	A BriaCell Therapeutics Corp. (TSE:BCT) insider increased their holdings by 20% last year (Simply Wall St.)
Mar-09-23 04:56AM	BCTX: 82% Survival Benefit (Zacks Small Cap Research) -10.14%
Feb-23-23 08:00AM	BriaCell Reports Positive Survival Data in Advanced Metastatic Breast Cancer (GlobeNewswire)
Feb-11-23 07:13AM	BriaCell Therapeutics Corp. (TSE:BCT) most popular amongst individual investors who own 59%, insiders hold 14% (Simply Wall St.)
Feb-09-23 11:09PM	BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting (GlobeNewswire)
Jan-24-23 09:07AM	BriaCell CEO Letter to Shareholders (GlobeNewswire)
Jan-23-23 12:06PM	BriaCell to investigate alleged illegal trading activity by outsiders (American City Business Journals) +5.68%
08:41AM	BriaCell to Investigate Alleged Illegal Trading of Public Securities (GlobeNewswire)
Jan-20-23 12:15PM	Lab Notes: Amicus founder gets national honor; Capstan and Code Bio land on list of companies to watch (American City Business Journals)
Jan-18-23 08:47AM	BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT Combination in Advanced Metastatic Breast Cancer (GlobeNewswire) -7.06%
Jan-10-23 09:00AM	BriaCell Announces New Patent Issuance, Bria-OTS IND Timing Guidance, and Additional Clinical Sites to Boost Enrolment (GlobeNewswire) +9.62%
Dec-19-22 06:16AM	BCTX: Down in San Antone (Zacks Small Cap Research) -5.39%
Dec-08-22 09:25AM	BriaCell Announces Positive Clinical and Quality of Life Data in Advanced Metastatic Breast Cancer at 2022 San Antonio Breast Cancer Symposium® (GlobeNewswire)
Dec-02-22 10:00AM	BriaCells Lead Candidate Bria-IMT Shows Promising Results For Advanced Breast Cancer Patients (News Direct)
Nov-30-22 08:04AM	IPAs Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies (Business Wire)
Nov-21-22 05:10AM	BCTX: SITC Poster Presentation (Zacks Small Cap Research)
Nov-15-22 08:00AM	BriaCell CEO Discusses Positive Clinical Results of its Breast Cancer Immunotherapy Treatment in an Audio Interview with SmallCapVoice.com (GlobeNewswire)
Nov-10-22 09:00AM	BriaCell Reports Positive Breast Cancer Efficacy Data with Bria-IMT Immunotherapy Treatment at SITC Annual Meeting (GlobeNewswire) +5.39%
Oct-31-22 07:54AM	BCTX: Fiscal Year 2022 Results (Zacks Small Cap Research)
Oct-21-22 09:00AM	BriaCell Announces Successful Completion of Phase I Portion of Clinical Study in Advanced Breast Cancer; Randomized Phase II Efficacy Evaluation Progressing (GlobeNewswire)
Oct-14-22 07:13AM	Here's Why We're Not Too Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation (Simply Wall St.)
Oct-12-22 09:00AM	BriaCell Announces New Clinical Trial Site to Bring Novel Cancer Treatments to Advanced Breast Cancer Patients (GlobeNewswire) +5.70%
Sep-28-22 09:15AM	BriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7th (GlobeNewswire)
Sep-14-22 09:20AM	BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling (GlobeNewswire)
Sep-07-22 09:25AM	BriaCell Announces Presentation at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Aug-17-22 10:13AM	What Type Of Shareholders Own The Most Number of BriaCell Therapeutics Corp. (TSE:BCT) Shares? (Simply Wall St.)
Aug-05-22 02:41PM	BriaCell signs exclusive licensing deal with UMBC for cancer treatment candidate (American City Business Journals)
Aug-04-22 09:00AM	BriaCell Secures License for a Promising Novel Anti-Cancer Agent (GlobeNewswire)
Jul-21-22 08:23AM	BriaCell Therapeutics Corp. (TSE:BCT) insider upped their holding earlier this year (Simply Wall St.)

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lustig Marc	Director	May 14 '24	Buy	2.21	902,935	2,000,001	2,542,935	May 20 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BCTX

BriaCell Therapeutics Corp

Upgrade your FINVIZ experience